Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul 7;2010(7):CD007792.
doi: 10.1002/14651858.CD007792.pub2.

Palliative surgery versus medical management for bowel obstruction in ovarian cancer

Ali Kucukmetin  1 , Raj Naik, Khadra Galaal, Andrew Bryant, Heather O Dickinson
Affiliations

Palliative surgery versus medical management for bowel obstruction in ovarian cancer

Ali Kucukmetin et al. Cochrane Database Syst Rev. .

Abstract

Background: Ovarian cancer is the sixth most common cancer among women and is usually diagnosed at an advanced stage. Bowel obstruction is a common feature of advanced or recurrent ovarian cancer. Patients with bowel obstruction are generally in poor physical condition with a limited life expectancy. Therefore, maintaining their QoL with effective symptom control is the main purpose of the management of bowel obstruction.

Objectives: To compare the effectiveness and safety of palliative surgery (surgery performed to control the cancer, reduce symptoms and improve quality of life for those whose cancer is not able to be entirely removed) and medical management for bowel obstruction in women with ovarian cancer.

Search strategy: We searched the Cochrane Gynaecological Cancer Group Trials Register, The Cochrane Central Register of Controlled trials (CENTRAL), Issue 1 2009, MEDLINE and EMBASE up to February 2009. We also searched registers of clinical trials, abstracts of scientific meetings, reference lists of included studies and contacted experts in the field.

Selection criteria: Studies that compared palliative surgery and medical interventions, in adult women diagnosed with ovarian cancer who had either full or partial obstruction of the bowel. Randomised controlled trials (RCTs) and non-RCTs that used multivariable statistical adjustment for baseline case mix were eligible.

Data collection and analysis: Two review authors independently assessed whether potentially relevant studies met the inclusion criteria, abstracted data and assessed risk of bias. One non-randomised study was identified so no meta-analyses were performed.

Main results: The search strategy identified 183 unique references of which 22 were identified as being potentially eligible on the basis of title and abstract. Only one study met our inclusion criteria and was included in the review. It analysed retrospective data for 47 women who received either palliative surgery (n = 27) or medical management with Octreotide (n = 20) and reported overall survival and perioperative mortality and morbidity. Women with poor performance status were excluded from surgery. Although six (22%) women who received surgery had serious complications of the operation and three (11%) died of complications, multivariable analysis found that women who received surgery had significantly (p < 0.001) better survival than women who received Octreotide, after adjustment for important prognostic factors. However, the magnitude of this effect was not reported. Quality of life (QoL) was not reported and adverse events were incompletely documented.

Authors' conclusions: We found only low quality evidence comparing palliative surgery and medical management for bowel obstruction in ovarian cancer. Therefore we are unable to reach definite conclusions about the relative benefits and harms of the two forms of treatment, or to identify sub-groups of women who are likely to benefit from one treatment or the other. However, there is weak evidence in support of surgical management to prolong survival.

PubMed Disclaimer

Conflict of interest statement

None known

Figures

1
1
Methodological quality summary: review authors' judgements about each methodological quality item for each included study.
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD007792

References

References to studies included in this review

Mangili 2005 {published data only}
    1. Mangili G, Aletti G, Frigerio L, Franchi M, Panacci N, Vigano` R, et al. Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis. International Journal of Gynecological Cancer 2005;15:830–35. - PubMed

References to studies excluded from this review

Arvieux 2005 {published data only}
    1. Arvieux C, Laval G, Mestrallet JP, Stefani L, Villard ML, Cardin N. Treatment of malignant intestinal obstruction.A prospective study over 80 cases. Annales de Chirurgie 2005;130(doi:10.1016/j.anchir.2005.05.011):470–476. - PubMed
Bais 1995 {published data only}
    1. Bais JM, Schilthuis MS, Slors JF, Lammes FB. Intestinal obstruction in patients with advanced ovarian cancer. International Journal of Gynecological Cancer 1995;5(5):346‐50. - PubMed
Bryan 2006 {published data only}
    1. Bryan DN, Radbod R, Berek JS. An analysis of surgical versus chemotherapeutic intervention for the management of intestinal obstruction in advanced ovarian cancer. International Journal of Gynecological Cancer 2006;16:125–134. - PubMed
Dinstl 1976 {published data only}
    1. Dinstl K, Hofbauer F, Schiessel R, Tuchmann A. [Mechanical ileus (author's transl)]. [German]. Zentralblatt fur Chirurgie 1976;101(23):1420‐6. - PubMed
Gadducci 1998 {published data only}
    1. Gadducci A, Iacconi P, Fanucchi A, Cosio S, Miccoli P, Genazzani AR. Survival after intestinal obstruction in patients with fatal ovarian cancer: Analysis of prognostic variables. International Journal of Gynecological Cancer 1998;8(3):177‐82.
Glass 1973 {published data only}
    1. Glass RL, LeDuc RJ. Small intestinal obstruction from peritoneal carcinomatosis. American Journal of Surgery 1973;125:316–7. - PubMed
Krouse 2002 {published data only}
    1. Krouse RS, McCahill LE, Easson AM, Dunn GP. When the sun can set on an unoperated bowel obstruction: Management of malignant bowel obstruction. Journal of the American College of Surgeons 2002;195(1):117‐28. - PubMed
Krouse 2008 {published data only}
    1. Krouse RS. The Value of a Systematic Approach to Malignant Bowel Obstruction. The Journal of Supportive Oncology 2008;6(3):116‐17. - PubMed
Larson 1989 {published data only}
    1. Larson J E, Podczaski E S, Manetta A, Whitney C W, Mortel R. Bowel obstruction in patients with ovarian carcinoma: analysis of prognostic factors. Gynecologic Oncology 1989;35(1):61‐5. - PubMed
Laval 2007 {published data only}
    1. Laval G, Beziaud N, Germain E, Rebischung C, Arvieux C. Management of obstructions due to carcinomatous peritonitis. Hepato‐Gastro 2007;14(6):465‐73.
Li 2004 {published data only}
    1. Li Z T, Wu X H, Fu SL. [Benefit of palliative surgery for bowel obstruction in recurrent ovarian carcinoma]. [Chinese]. Chung‐Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics & Gynecology] 2004;39(4):260‐3. - PubMed
Lund 1989 {published data only}
    1. Lund B, Hansen M, Lundvall F, Nielsen N C, Sorensen B L, Hansen HH. Intestinal obstruction in patients with advanced carcinoma of the ovaries treated with combination chemotherapy. Surgery, Gynecology & Obstetrics 1989;169(3):213‐8. - PubMed
Medina‐Franco 2008 {published data only}
    1. Medina‐Franco H, Garcia‐Alvarez M N, Ortiz‐Lopez L J, Cuairan J Z. Predictors of adverse surgical outcome in the management of malignant bowel obstruction. Revista de Investigacion Clinica 2008;60(3):212‐6. - PubMed
Miller 2000 {published data only}
    1. Miller G, Boman J, Shrier I, Gordon PH. Small‐bowel obstruction secondary to malignant disease: an 11‐year audit. Canadian Association of General Surgeons 2000;43(No. 5):353‐58. - PMC - PubMed
Onsrud 2001 {published data only}
    1. Onsrud M, Hagen B, Heimstad R. [Palliative treatment in gynecologic cancer]. [Norwegian]. Tidsskrift for Den Norske Laegeforening 2001;121(16):1896‐901. - PubMed
Paganelli 1990 {published data only}
    1. Paganelli A M, Leone V, Malagutti V, Vescovo M, Sallusto A. Intestinal surgery in patients with ovarian carcinoma. European Journal of Gynaecological Oncology 1990;11(2):157‐60. - PubMed
Ross 2006 {published data only}
    1. Ross AS, Semrad C, Waxman I, Dye C. Enteral stent placement by double balloon enteroscopy for palliation of malignant small bowel obstruction. Gastrointestinal Endoscopy 2006;64(5):835‐37 (doi:10.1016/j.gie.2006.03.001). - PubMed
Sartori 2009 {published data only}
    1. Sartori E, Chiudinelli F, Pasinetti B, Maggino T. Bowel Obstruction and Survival in Patients With Advanced Ovarian Cancer. Analysis of Prognostic Variables. International Journal of Gynecological Cancer 2009;19:54‐57. - PubMed
    1. Sartori E, Chiudinelli F, Pasinetti B, Zanagnolo V. Palliative care in advanced ovarian cancer patients with bowel obstruction. Gynecologic Oncology 2005;99(doi:10.1016/j.ygyno.2005.07.088):S215–S216. - PubMed
Scheidbach 1999 {published data only}
    1. Scheidbach H, Horbach TH, Groitl H, Hohenberger W. Percutaneous endoscopic gastrostomy/jejunostomy (PEG/PEJ) for decompression in the upper gastrointestinal tract: Initial experience with palliative treatment of gastrointestinal obstruction in terminally ill patients with advanced carcinomas. Surgical Endoscopy 1999;13:1103–5. - PubMed
Xinopoulos 2004 {published data only}
    1. Xinopoulos D, Dimitroulopoulos D, Theodosopoulos T, Tsamakidis K, Bitsakou G, Plataniotis G, et al. Stenting or stoma creation for patients with inoperable malignant colonic obstructions? Results of a study and cost‐effectiveness analysis. Surgical Endoscopy 2004;18(DOI: 10.1007/s00464‐003‐8109‐x):421–26. - PubMed

Additional references

Bryan 2006
    1. Bryan DN, Radbod R, Berek JS. An analysis of surgical versus chemotherapeutic intervention for the management of intestinal obstruction in advanced ovarian cancer. International Journal of Gynecological Cancer 2006;16:125‐34. - PubMed
Bucher 1997
    1. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta‐analysis of randomized controlled trials. Journal of Clinical Epidemiology 1997;50(6):683‐91. - PubMed
Caceres 2008
    1. Caceres A. Colorectal stents for palliation of large‐bowel obstructions in recurrent gynecologic cancer: an updated series. Gynecologic Oncology 2008;108(3):482‐5. - PubMed
Caprotti 2006
    1. Caprotti R. Palliative surgery for recurrent bowel obstruction due to advanced ovarian cancer. Minerva Ginecologica 2006;58(3):239‐44. - PubMed
Clarke‐Pearson 1987
    1. Clarke‐Pearson DL. Surgical management of intestinal obstruction in ovarian cancer. I. Clinical features, postoperative complications, and survival. Gynecologic Oncology 1987;26(1):11‐8. - PubMed
Clayton 2005
    1. Clayton N L, Jaaback K S, Hirschowitz L. Primary fallopian tube carcinoma – the experience of a UK cancer centre and a review of the literature. Journal of Obstetrics and Gynaecology 2005;25(7):694‐702. - PubMed
CTCAE 2006
    1. CTCAE. Common Terminology Criteria for Adverse Events. (http://ctep.cancer.gov/forms/CTCAEv3.pdf) 9th August 2006; Vol. v3.0 (CTCAE).
Deeks 2001
    1. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta‐analysis. In: Egger M, Davey Smith G, Altman DG (eds) editor(s). Systematic Reviews in Health Care: Meta‐Analysis in Context. 2nd Edition. London: BMJ Publication Group, 2001.
DerSimonian 1986
    1. DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7:177‐88. - PubMed
Dvoretsky 1988
    1. Dvoretsky PM. Survival time, causes of death, and tumor/treatment‐related morbidity in 100 women with ovarian cancer. Human Pathology 1988;19(11):1273‐9. - PubMed
EUROCARE 2003
    1. Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J et al the EUROCARE Working Group. EUROCARE‐3: survival of cancer patients diagnosed 1990‐94 ‐ results and commentary. Annals of Oncology 2003;14 (Supplement 5):v61‐v118. - PubMed
Fainsinger 1994
    1. Fainsinger RL, Spachynski K, Hanson J, Bruera E. Symptom control in terminally ill patients with malignant bowel obstruction. Journal of Pain and Symptom Management 1994;9:12‐8. - PubMed
Fallon 1994
    1. Fallon MT. The physiology of somatostatin and its synthetic analogue, octreotide. European Journal of Palliative Care 1994;1:20‐2.
Feuer 1999
    1. Feuer DJ, Broadley KE. Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database of Systematic Reviews 1999, Issue 3. Art. No.: CD001219. DOI: 10.1002/14651858.CD001219.. [DOI: 10.1002/14651858.CD001219] - DOI - PMC - PubMed
Feuer 2000
    1. Feuer DDJ, Broadley KE. Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database of Systematic Reviews 2000, Issue 3. Art. No.: CD002764. DOI: 10.1002/14651858.CD002764.. [DOI: 10.1002/14651858.CD002764.] - DOI - PubMed
GLOBOCAN 2002
    1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5, version 2.0. IARCPress, Lyon 2004.
GRADE Working Group
    1. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490‐94. - PMC - PubMed
Higgins 2003
    1. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327:557‐60. - PMC - PubMed
Higgins 2008
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org.
Jemal 2008
    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics. CA: A Cancer Journal for Clinicians 2008;58:71‐96. - PubMed
Mangili 1996
    1. G. Mangili, Franchi M, Mariani A. Octreotide in the management of bowel obstruction in terminal ovarian cancer. Gynecologic Oncology 1996;61:345‐8. - PubMed
Markman 2008
    1. Markman M. Pharmaceutical management of ovarian cancer: current status. Drugs 2008;68(6):771‐89. - PubMed
Mercadante 2004
    1. Mercadante S, Ferrera P, Villari P, Marrazzo A. Aggressive pharmacological treatment for reversing malignant bowel obstruction. Journal of Pain and Symptom Management 2004;28:412‐6. - PubMed
Ooijen 1993
    1. Ooijen B, Burg ME, Planting AS, Siersema PD, Wiggers T. Surgical treatment of gastric drainage only for intestinal obstruction in patients with carcinoma of the ovary or peritoneal carcinomatosis of other origin. Surgery, Gynecology and Obstetrics 1993;176(5):469‐74. - PubMed
Parmar 1998
    1. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815‐34. - PubMed
Pothuri 2003
    1. Pothuri B. Palliative surgery for bowel obstruction in recurrent ovarian cancer:an updated series. Gynecologic Oncology 2003;89(2):306‐13. - PubMed
Pothuri 2005
    1. Pothuri B, Montemarano M, Gerardi M, Shike M, Ben‐Porat L, Sabbatini P, et al. Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma. Gynecologic Oncology 2005;96(2):330‐4. - PubMed
Quinn 2001
    1. Quinn M, Babb P, Brock A, Kirby L, Jones J. Cancer Trends in England and Wales 1950–1999. Office for National Statistics 2001:http://www.statistics.gov.uk/downloads/theme_health/cancertrends_5099.pdf.
Quirk 2005
    1. Quirk JT, Natarajan N, Mettlin CJ. Age‐specific ovarian cancer incidence rate patterns in the United States. Gynecologic Oncology 2005;99(1):248‐50. - PubMed
Rabban 2005
    1. Rabban JT, Bell DA. Current issues in the pathology of ovarian cancer. Journal of Reproductive Medicine 2005 Jun;50(6):467‐74. - PubMed
Redman 1988
    1. Redman CW. Survival following intestinal obstruction in ovarian cancer. Eurupean Journal of Surgical Oncology 1988;14(5):383‐6. - PubMed
Reichlin 1983
    1. Reichlin S. Medical progress: somatostatin. New England Journal of Medicine 1983;309:1495‐501. - PubMed
Shepherd 1989
    1. Shepherd JH. Revised FIGO staging for gynaecological cancer. British Journal of Obstetrics and Gynaecology 1989;96(8):889‐92. - PubMed
Sundar 2006
    1. Sundar SS. Role of lymphangiogenesis in epithelial ovarian cancer. British Journal of Cancer 2006;94(11):1650‐7. - PMC - PubMed
Tunca 1981
    1. Tunca JC. The management of ovarian‐cancer‐caused bowel obstruction. Gynecologic Oncology 1981;12:186‐92. - PubMed

Publication types

MeSH terms